What is tissue fibrosis?
tissue fibrosis is a condition in which fibrous tissue attacks the organ. The tissue of the scar is formed as a process of repair and tissue solidifies, which reduces the flow of liquid. The condition is usually caused by injury, inflammation and burns. Unusual causes include radiation, chemotherapy and incorrect lymphedema processing. The effects of tissue fibrosis and treatment depend on its location: liver, secretory and lungs are commonly affected areas.
liver fibrosis is the accumulation of excess tissue of scar in the liver. Over time, it disrupts the metabolic function of the liver and could lead to cirrhosis, the final phase of chronic liver disease. Severe consumption of alcohol, steatosis and the use of immunosuppressive drugs contribute to the development of the condition.
It is known that insulin resistance and HIV accelerate the process of tissue fibrosis in the liver. Treatment options include antibiotics, vitamin coagulopathy and other blood products and encephalopathy. Patients are also recommended to completely stop alcohol consumption and reduce salt intake. PacEnti in advanced cirrhosis stages are often candidates for liver transplantation.
Cystic fibrosis (CF) is a genetic disease of secretory glands in which body fluids such as hock and sweat, sticky and stronger than usual are. One defective gene found in chromosome 7 - chromosome that controls the movement of water and salt in and out of cells - is a hereditary cause of CF. Tissue fibrosis of this species usually affect the intestines, pancreas or liver. Lungs, cavities and sexual organs may also be affected.
Although no medicine has been developed for CF, the condition may be significantly manageable, several viable treatments such as physical therapy (CPT) and oxygen therapy. Intravenous, oral and inhaby also found that LED drugs alleviate the symptoms of tissue fibrosis. Patients with advanced lung disease may opt for lung transplantation, although the procedure carries many risks.
In the lung fibrosis, excessive fibrous connective tissue develops in the lungs. The condition is often referred to as "scarring of the lungs" and may be a secondary effect of other interstitial lung diseases. In some cases, it could be idiopathic pulmonary fibrosis (IDP) or cyptogenic fibrosis alveolitis (CFA), a disease in which the cause is unknown. Symptoms include shortness of breath (shortness of breath), dry cough and significantly reduced exercise. Since the scarring is permanent, there is no evidence that tissue fibrosis in the lungs can be treated with medicines, although it can help prevent further damage and alleviating symptoms.